REQUEST A DEMO
Total
USD $0.00
Search more companies

Glyconex Incorporation (台湾醣联生技医药股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Glyconex Incorporation Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Glyconex Incorporation (台湾醣联生技医药股份有限公司) is a company based in Taiwan, China, with its head office in New Taipei City. It operates in the Pharmaceutical and Medicine Manufacturing industry. Glyconex Incorporation (台湾醣联生技医药股份有限公司) was incorporated on February 01, 2001. It currently has a total number of 56 (2023) employees. In Q3C2025, the company reported a net sales revenue increase of 190.34%. Its total assets grew by 12.72% over the same period. Glyconex Incorporation (台湾醣联生技医药股份有限公司)’s net profit margin increased by 985.66% in 2025.

Headquarters
8F., No.97, Sec. 1, Xintai 5Th Rd., Xizhi Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the Glyconex Incorporation (台湾醣联生技医药股份有限公司) report to view the information.

Website: http://www.glyconex.com.tw

Basic Information
Total Employees:
Purchase the Glyconex Incorporation (台湾醣联生技医药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Glyconex Incorporation (台湾醣联生技医药股份有限公司) report to view the information.
Financial Auditors:
Purchase the Glyconex Incorporation (台湾醣联生技医药股份有限公司) report to view the information.
Incorporation Date:
February 01, 2001
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
3.97%
Purchase this report to view the information.
2.88%
Purchase this report to view the information.
2.8%
Purchase this report to view the information.
2.03%
Purchase this report to view the information.
1.9%
Subsidiaries
醣聯投資股份有限公司
100%
Company Performance
Financial values in the chart are available after Glyconex Incorporation (台湾醣联生技医药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
190.34%
Total Operating Revenue
116.07%
Operating Profit
13.75%
EBITDA
16.64%
Net Profit/Loss for the Period
7.26%
Total Assets
12.72%
Total Equity
-8.86%
Operating Profit Margin
1059.91%
Net Profit Margin
985.66%
Return on Equity (ROE)
-0.26%
Debt / Equity
46635%
Quick Ratio
9204.58%
Cash Ratio
7.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?